Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

NIH 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 10Gastrointestinal 9Lymphoid 8Sarcoma 4Other hematologic neoplasm 4Thoracic 3Dermatologic 2Plasma cell 1Other 1Genitourinary 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 1883Lung Neoplasms 1308Small Cell Lung Carcinoma 329Colorectal Neoplasms 271Breast Neoplasms 243Melanoma 221Neoplasms 218Ovarian Neoplasms 193Neoplasm Metastasis 181Pancreatic Neoplasms 155Squamous Cell Carcinoma of Head and Neck 152Stomach Neoplasms 143Head and Neck Neoplasms 120Carcinoma, Renal Cell 119Triple Negative Breast Neoplasms 111Esophageal Neoplasms 109Prostatic Neoplasms 107Endometrial Neoplasms 98Uterine Cervical Neoplasms 97Urinary Bladder Neoplasms 89Mesothelioma 88Colonic Neoplasms 86Mesothelioma, Malignant 81Carcinoma, Hepatocellular 74Brain Neoplasms 70Sarcoma 64Disease 63Adenocarcinoma of Lung 60Carcinoma, Transitional Cell 54Liver Neoplasms 49

Interventions

Specimen Handling 2Nivolumab 2Magnetic Resonance Spectroscopy 2cabozantinib 1Ipilimumab 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
HIV Infections × Thoracic × 1 year × Clear all
NCT04514484 2026-05-28

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

National Cancer Institute (NCI)

Phase 1 Active not recruiting
8 enrolled 32 charts
BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Kaposi, HIV Infections, Carcinoma, Medullary, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT01207986 2026-04-23

EP48 HIV CHEST

ANRS, Emerging Infectious Diseases

Phase NA Completed
450 enrolled
Thoracic

Lung Neoplasms, HIV Infections

NCT02408861 2026-01-21

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

National Cancer Institute (NCI)

Phase 1 Terminated
79 enrolled 24 charts
GastrointestinalSarcomaThoracic

Anus Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡